unknown
Stage
1
Investors
About
CARGO Therapeutics develops antibody-drug conjugate (ADC) therapies aimed at treating oncology indications by advancing pre-clinical to clinical proof-of-concept stages.
Explore CARGO Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.